telogen effluvium glp 1 Hair loss reported during GLP-1 therapy is most commonly explained by effluvium, a delayed response to rapid weight loss and undernutrition. ‌ Two key contributors I assess clinically: 👉🏻Low protein intake GLP-1 Inhibitors and Hairloss —

This Fountain of youth drip reduces oxidative cell damage thereby age associated degenerative disease

Imaging findings consistent with pancreatitis Laboratory Findings * Elevated serum lipase (more specific) * Elevated serum amylase * Leukocytosis * Elevated CRP * Hyperglycemia * Abnormal liver function tests (gallstone pancreatitis) Imaging * Abdominal ultrasound (detect gallstones) * Contrast-enhanced CT abdomen (assess severity and complications) * MRI/MRCP if indicated Severity Assessment Ranson Criteria Glasgow Score BISAP Score Used to predict severity and mortality risk

References 1 AbdullahL.EvansJ

*Journal of Physiology and Pharmacology*, 63(4), 475-482

Supplementary information Source data Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made

Verificacin mediante CheckMySupps NutraBio permite consultar informacin de control de calidad y resultados disponibles mediante su sistema CheckMySupps